Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 12 · Randomised trials: 4 · 1993–2026
Showing the 50 most relevant studies, sorted by most relevant.
Reza Amini M, Kazeminejad S, Jalalzadeh M, et al.
2024
- Fatty Alcohols
- Blood Glucose
- Dietary Supplements
Gholamrezayi A, Amini MR, Rasaei N, et al.
2024
- Liver
- Dietary Supplements
- Fatty Alcohols
Mohammad Reza Amini, Sara Sadeghi Majd, Marieh Salavatizadeh, et al.
BMC Complementary Medicine and Therapies, 2025
- Fatty Alcohols
- Creatinine
- Antioxidants
Parinitha A, Navjot Kaur, Poonam Aggarwal, et al.
Food and Humanity, 2025
Rilton Gonçalo Bonfim Primo, Manuel Díaz de los Ríos, Ricardo de Araújo Kalid
Revista DCS, 2025
This study presents a comprehensive scientometric protocol designed to analyze six principal biorefining routes for Policosanol (Pc) extraction. By integrating experimental parameters, publication metrics, and patent indicators, the research reveals asymmetries and convergences across methods such as saponification, solvent extraction, ultrasonic-assisted techniques, molecular distillation, transesterification, and supercritical CO₂. A cross-meta-analysis of articles, reviews, and patents was conducted using Scopus, Web of Science, Intellectual Property (IP) Business Intelligence modality of Orbit® seekers (version 1.9.8) and SciFinder databases. An innovative set of five scientometric indices was applied to the literature as an analytical method, combined with the Technology Readiness Levels (TRL - NASA) and Maturity Readiness Level (MRL - Embrapa) metrics. Completing the methodology, the structured pyramid protocol enabled advanced mapping of international scientific networks and technology readiness levels. Notably, ultrasonic-assisted extraction and transesterification exhibit strong alignment between academic output and industrial interest, while saponification and solvent extraction show marked dissociation especially within the Ibero-American context. This framework offers a replicable model for assessing innovation dynamics and technological convergence in Pc research, supporting future developments in cardiovascular-relevant bioproducts.
Abstract licence: CC BY-NC 4.0
Rilton Gonçalo Bonfim Primo, Manuel Díaz de los Ríos, Ricardo de Araújo Kalid
Derecho y Cambio Social, 2025
This Cross-Meta-Analysis, based on PROSPERO Protocol (CRD42023425955), addresses two gaps by conducting a regionalized and simultaneous analysis of articles and patents on the six main Policosanol biorefining routes - a multifunctional antihypercholesterolemic - within the dual context of the burgeoning global bioeconomy and strategies for the prevention and treatment of cardiovascular diseases, the leading cause of death worldwide. Most reviews focus on clinical applications, without comparing extraction methods and evaluating their uncertainties. This study employs extensive databases, and high-end bibliometric tools such as Bibliometrix and Orbit Business Intelligence, while examining 18 Ibero-American countries. The main inferences on efficiencies are the advances of Cuba, Spain, Brazil, Chile, Mexico and Portugal, as well as the need for greater academic-industrial coordination amongst themselves. Covering 16 raw materials, highlighting lacquer wax, sugar cane wax, rice bran wax and Ericerus Pela wax, yield analysis reveals: High (0.511 ≤ yield ≤ 0.700): three methods; Moderate (0.381 ≤ yield ≤ 0.510): four methods; Low (0.251 ≤ yield ≤ 0.380): seven methods. These yields signal clear directions for further research, according to biomes and local costs, being useful as a guide for laboratory research, industrial applications and decision makers.
Abstract licence: CC BY-NC 4.0
Askarpour M, Ghaedi E, Roshanravan N, et al.
2019
- Fatty Alcohols
- Blood Pressure
- Dietary Supplements
Cho KH, Nam HS, Baek SH, et al.
2023
- Lipoproteins, HDL
- Anticholesteremic Agents
- Fatty Alcohols
This study evaluated the efficacy and safety of 20 mg of Cuban policosanol in blood pressure (BP) and lipid/lipoprotein parameters of healthy Japanese subjects via a placebo-controlled, randomized, and double-blinded human trial. After 12 weeks of consumption, the policosanol group showed significantly lower BP, glycated hemoglobin (HbA1c), and blood urea nitrogen (BUN) levels. The policosanol group also showed lower aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transferase (γ-GTP) levels at week 12 than those at week 0: A decrease of up to 9% (p p p p p = 0.003), respectively, than the placebo group and a difference in the point of time and group interaction (p 1c with enhancement of HDL functionalities.
Abstract licence: CC BY
Anesthesia and Medical Practice Journal, 2017
Ioanna Gouni-Berthold, Heiner K. Berthold
American Heart Journal, 2002
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.